iShares U.S. Healthcare ETF (IYH)
| Assets | $3.98B |
| Expense Ratio | 0.37% |
| PE Ratio | 25.78 |
| Shares Out | 54.35M |
| Dividend (ttm) | $0.80 |
| Dividend Yield | 1.10% |
| Ex-Dividend Date | Sep 15, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 28.43% |
| Volume | 64,695 |
| Open | 72.04 |
| Previous Close | 72.44 |
| Day's Range | 72.04 - 72.75 |
| 52-Week Low | 56.44 |
| 52-Week High | 74.59 |
| Beta | 0.59 |
| Holdings | 104 |
| Inception Date | Jun 12, 2000 |
About IYH
Fund Home PageThe iShares U.S. Healthcare ETF (IYH) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a cap-weighted index of pharmaceutical, biotechnology, health care services and equipment companies in the US. IYH was launched on Jun 12, 2000 and is issued by BlackRock.
Top 10 Holdings
58.72% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 14.70% |
| Johnson & Johnson | JNJ | 10.16% |
| AbbVie Inc. | ABBV | 7.28% |
| Merck & Co., Inc. | MRK | 5.72% |
| UnitedHealth Group Incorporated | UNH | 5.29% |
| Thermo Fisher Scientific Inc. | TMO | 3.90% |
| Amgen Inc. | AMGN | 3.48% |
| Gilead Sciences, Inc. | GILD | 2.92% |
| Abbott Laboratories | ABT | 2.73% |
| Pfizer Inc. | PFE | 2.54% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 15, 2026 | $0.19083 | Sep 18, 2026 |
| Jun 15, 2026 | $0.16336 | Jun 18, 2026 |
| Mar 17, 2026 | $0.19482 | Mar 20, 2026 |
| Dec 16, 2025 | $0.24969 | Dec 19, 2025 |
| Sep 16, 2025 | $0.19284 | Sep 19, 2025 |
| Jun 16, 2025 | $0.16819 | Jun 20, 2025 |
Performance
IYH had a total return of 27.52% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.20%.
News
Final Trades: IBM, Alibaba, Nu Holdings and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Taiwan Semi, Abbvie, Tradeweb Markets and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Vertiv Holdings, Spotify and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Disney, Ashtead Group, Trade Desk and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: John Deere, Copart, Amgen and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: KKR & Co, Leidos Holdings, Abbvie, and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Interactive Brokers, Delta, the SMIN and IYH
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: JNJ, M, IYH & CLF
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Final Trades: Target, Las Vegas Sands, Apollo Global and the IYH
The Investment Committee share their top stocks in the second half.
Final Trades: Shake Shack, Pfizer, Humana and iShares US Healthcare
The 'Halftime Report' traders give their top picks to watch for.
Fundamentals for M&A in healthcare sector remain really strong, says Guggenheim's Mehta
Punit Mehta, Guggenheim Securities head of healthcare investment banking, joins 'Squawk on the Street' to discuss the healthcare M&A market, how Mehta sees the growth of the new class of weight-loss d...
Government shutdown fears are growing. Here's what to watch, and when to expect trouble.
Fresh off the debt-ceiling showdown, Washington may be looking at another fiscal crisis: a government shutdown.
Final Trades: Progressive, Dollar General, Seagate & more
The "Halftime Report" traders give their top picks to watch for the second half.
Best ETFs to Buy in a Recession for August 2022
We've had some sizeable dips in the market lately, followed by quick bursts upward. Interest rates have increased, but there is still talk of a possible recession ahead even though some data point to ...
Add Up The Parts: The IShares U.S. Healthcare ETF Could Be Worth $235
For the iShares U.S. Healthcare ETF (IYH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $235.37 per unit.
Final trades: Wendy's, Roku, Tanger, Alibaba, and more
The "Halftime Report" traders give their top stocks to watch for the second half
Peek Under The Hood: The iShares U.S. Healthcare ETF Has 19% Upside
For the iShares U.S. Healthcare ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $219.78 per unit.
Analysts Expect 12% Gains Ahead For The iShares U.S. Healthcare ETF
For the iShares U.S. Healthcare ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $217.98 per unit.
Peek Under The Hood: The iShares U.S. Healthcare ETF Has 11% Upside
For the iShares U.S. Healthcare ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $217.51 per unit.
Look Under The Hood: The iShares U.S. Healthcare ETF Has 10% Upside
For the iShares U.S. Healthcare ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $217.72 per unit.
Add Up The Parts: The iShares U.S. Healthcare ETF Could Be Worth $217
For the iShares U.S. Healthcare ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $216.79 per unit.
Surprising Analyst 12-Month Target For The iShares U.S. Healthcare ETF
For the iShares U.S. Healthcare ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $217.09 per unit.
Peek Under The Hood: The iShares U.S. Healthcare ETF Has 17% Upside
For the iShares U.S. Healthcare ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $216.85 per unit.
Peek Under The Hood: The iShares U.S. Healthcare ETF Has 12% Upside
or the iShares U.S. Healthcare ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $217.06 per unit.